Biodesix (BDSX) Total Debt (2019 - 2026)

Biodesix (BDSX) has 8 years of Total Debt data on file, last reported at $46.5 million in Q1 2026.

• Quarterly Total Debt rose 26.69% year-over-year to $46.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.5 million (up 26.69% YoY) and the FY2025 annual result came in at $47.4 million, up 30.31% from the prior year.
• Total Debt retreated to $46.5 million in Q1 2026, from $47.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $57.1 million in Q4 2023 to a low of $14.2 million in Q3 2022.
• A 5-year average of $39.1 million and a median of $39.2 million in 2023 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt sank 67.13% — and 2023, when it surged 212.42%.
• Tracing BDSX's Total Debt over 5 years: stood at $35.3 million in 2022, then surged by 61.5% to $57.1 million in 2023, then slumped by 36.22% to $36.4 million in 2024, then soared by 30.31% to $47.4 million in 2025, then retreated by 2.02% to $46.5 million in 2026.
• The last three Total Debt figures came in at $46.5 million (Q1 2026), $47.4 million (Q4 2025), and $47.1 million (Q3 2025), per Business Quant data.